Measuring the size of hypertrophic scars and keloids using 3D cameras after surgery
Quantification of Hypertrophic Scar Tissue or Keloid Using a 3D-Camera
This study is testing whether a 3D camera can help measure the size of scars and keloids in patients after surgery to see how they change over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Trial ID | NCT06806735 on ClinicalTrials.gov |
What this trial studies
This study aims to measure the volumes of hypertrophic scars and keloids in patients who have undergone surgery, using a 3D camera at various time points: day 0, 3 months, 6 months, and 12 months post-surgery. The focus is on evaluating the effectiveness of the 3D camera as a tool for measuring and documenting scar volumes through volumetry. By capturing detailed three-dimensional images, the study seeks to provide a more accurate assessment of scar progression over time.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have hypertrophic scars or keloids following surgery.
Not a fit: Patients without hypertrophic scars or keloids, or those unable to provide consent, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of hypertrophic scars and keloids, leading to better treatment strategies.
How similar studies have performed: While the use of 3D imaging in medical assessments is growing, this specific approach to measuring scar volumes is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years. Exclusion Criteria: * Absence of written consent, unwillingness to contribute data, inability to understand the study protocol. * lack of hypertrophic scars or keloid
Where this trial is running
Zurich, Canton of Zurich
- Universitätsspital Zürich — Zurich, Canton of Zurich, Switzerland (Recruiting)
Study contacts
- Study coordinator: Prof. Dr. med. Soyka
- Email: rhinologie@usz.ch
- Phone: +41 44 255 58 33
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.